Form D Explorer
Syncromune, Inc. · CIK 1955312

Report a data issueCitable research briefCompare issuerPrivate research collection

Syncromune, Inc.

CIK 1955312 · Corporation · Inc. DELAWARE · FORT LAUDERDALE, Florida · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
0
Amendments
2
Activity
Aug 21, 2025
through May 11, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldAug 21, 2025 · D/AMay 11, 2026 · D/ALater minus earlier
Reported offering amount$144,828,791$144,828,791$0
Reported amount sold$111,828,793$144,828,791$32,999,998
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001231919-25-000158 · Later SEC source: 0001231919-26-000472

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · May 11, 2026

Reported offering amount
$144,828,791
Reported exemptions
Rule 506(b)
Reported amount sold
$144,828,791

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (2)